Related Experiment Video
Updated: Nov 4, 2025

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
Published on: December 5, 2016
N6-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic
Yuanming Cheng1, Wei Xie2, Brian F Pickering3
1Molecular Pharmacology Program, Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Abstract:
N6-Methyladenosine (m6A) on mRNAs mediates different biological processes and its dysregulation contributes to tumorigenesis. How m6A dictates its diverse molecular and cellular effects in leukemias remains unknown. We found that YTHDC1 is the essential m6A reader in myeloid leukemia from a genome-wide CRISPR screen and that m6A is required for YTHDC1 to undergo liquid-liquid phase separation and form nuclear YTHDC1-m6A condensates (nYACs). The number of nYACs increases in acute myeloid leukemia (AML) cells compared with normal hematopoietic stem and progenitor cells. AML cells require the nYACs to maintain cell survival and the undifferentiated state that is critical for leukemia maintenance. Furthermore, nYACs enable YTHDC1 to protect m6A-mRNAs from the PAXT complex and exosome-associated RNA degradation. Collectively, m6A is required for the formation of a nuclear body mediated by phase separation that maintains mRNA stability and control cancer cell survival and differentiation.
Insights
Nuclear m6A condensates (nYACs) are essential for acute myeloid leukemia (AML) cell survival and differentiation. YTHDC1 protein forms these condensates, protecting mRNA from degradation and maintaining leukemia progression.
Area of Science:
- Molecular Biology
- Cancer Biology
- Epigenetics
Background:
- N6-Methyladenosine (m6A) modification on mRNAs regulates biological processes.
- Dysregulation of m6A is implicated in tumorigenesis, but its role in leukemia is unclear.
Purpose of the Study:
- To investigate the role of m6A and its readers in myeloid leukemia.
- To elucidate the molecular mechanisms by which m6A influences leukemia cell biology.
Main Methods:
- Genome-wide CRISPR screen to identify essential m6A readers.
- Analysis of nuclear YTHDC1-m6A condensates (nYACs) in leukemia cells.
- Investigation of YTHDC1's role in mRNA stability and degradation pathways.
Main Results:
- YTHDC1 was identified as a critical m6A reader in myeloid leukemia.
- m6A facilitates YTHDC1 liquid-liquid phase separation, forming nYACs, which are increased in AML cells.
- nYACs are crucial for AML cell survival, maintaining an undifferentiated state, and protecting m6A-mRNAs from degradation by the PAXT complex and exosome.
Conclusions:
- m6A is essential for forming phase-separated nuclear bodies (nYACs) that maintain mRNA stability.
- These nYACs are critical for controlling cancer cell survival and differentiation in leukemia.
More Related Videos
Related Concept Videos
Nuclear Export of mRNA
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
MicroRNAs
MicroRNAs
Abnormal Proliferation

